FI20050180A - Process for Preparing Delta 9,11-Chloro-Corticosteroids - Google Patents

Process for Preparing Delta 9,11-Chloro-Corticosteroids Download PDF

Info

Publication number
FI20050180A
FI20050180A FI20050180A FI20050180A FI20050180A FI 20050180 A FI20050180 A FI 20050180A FI 20050180 A FI20050180 A FI 20050180A FI 20050180 A FI20050180 A FI 20050180A FI 20050180 A FI20050180 A FI 20050180A
Authority
FI
Finland
Prior art keywords
steroids
chloro
delta
corticosteroids
beta
Prior art date
Application number
FI20050180A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI117599B (en
Inventor
Xiaoyong Fu
Tiruvettipuram K Thiruvengadam
Chou-Hong Tann
Junning Lee
Cesar Colon
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI20050180A publication Critical patent/FI20050180A/en
Application granted granted Critical
Publication of FI117599B publication Critical patent/FI117599B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Abstract

Described is a process for the regioselective dehydration of 11-hydroxy steroids using PCl5, PCl3, POCl3 or either SO2Cl2 and imidazole, or PPh3 and CCl4. The disclosed process selectively forms DELTA <9,11> steroids from either 11- alpha - or 11- beta -hydroxy steroids, and can also be used for the one-step conversion of 11,21-dihydroxy steroids to 21-chloro- DELTA <9,11> steroids. Also disclosed are processes for the regioselective conversion of 11- beta -chloro steroids to DELTA <9,11> steroids, and for regioselectively converting an 11,17,21-trihydroxy steroid to a 21-chloro-11,17-dihydroxy steroid.
FI20050180A 1994-06-01 2005-02-16 The method produces delta 9.11 chlorocorticosteroids FI117599B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/252,302 US5502222A (en) 1994-06-01 1994-06-01 Process for preparing delta 9,11 and 21-chloro corticosteroids
US25230294 1994-06-01
US9506600 1995-05-30
PCT/US1995/006600 WO1995032989A1 (en) 1994-06-01 1995-05-30 Process for preparing δ9,11 and 21-chloro corticosteroids

Publications (2)

Publication Number Publication Date
FI20050180A true FI20050180A (en) 2005-02-16
FI117599B FI117599B (en) 2006-12-15

Family

ID=22955451

Family Applications (3)

Application Number Title Priority Date Filing Date
FI964739A FI118801B (en) 1994-06-01 1996-11-28 The method produces delta9,11 steroids
FI20050180A FI117599B (en) 1994-06-01 2005-02-16 The method produces delta 9.11 chlorocorticosteroids
FI20050181A FI117600B (en) 1994-06-01 2005-02-16 The method produces 21-chlorocorticosteroids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI964739A FI118801B (en) 1994-06-01 1996-11-28 The method produces delta9,11 steroids

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20050181A FI117600B (en) 1994-06-01 2005-02-16 The method produces 21-chlorocorticosteroids

Country Status (18)

Country Link
US (3) US5502222A (en)
EP (3) EP0969011B1 (en)
JP (1) JP2831472B2 (en)
KR (4) KR100226568B1 (en)
AT (3) ATE188481T1 (en)
AU (1) AU696425B2 (en)
CA (1) CA2191324C (en)
DE (3) DE69535765D1 (en)
DK (1) DK0063054T3 (en)
ES (3) ES2306488T3 (en)
FI (3) FI118801B (en)
GR (1) GR3032714T3 (en)
HU (3) HU227378B1 (en)
IL (5) IL126597A (en)
MX (1) MX9605893A (en)
NZ (1) NZ287348A (en)
PT (1) PT763054E (en)
WO (1) WO1995032989A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
ES2287943T3 (en) 1995-12-11 2007-12-16 G.D. Searle Llc. PROCEDURE FOR THE PREPARATION OF AN EPOXIDE COMPOUND.
US6887991B1 (en) * 1996-12-11 2005-05-03 G. D. Searle & Company Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
PT944644E (en) 1996-12-11 2003-02-28 Searle & Co PROCESSES FOR THE PREPARATION OF 9,10-EPOXY ESTEROIDS AND USES INTERMEDIARIES FOR THAT EFFECT
CN100473660C (en) * 2002-03-22 2009-04-01 法玛西雅厄普约翰美国公司 Process for preparing eplerenone
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US7700603B2 (en) 2003-12-15 2010-04-20 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
US7592348B2 (en) 2003-12-15 2009-09-22 Schering Corporation Heterocyclic aspartyl protease inhibitors
JP2010512389A (en) 2006-12-12 2010-04-22 シェーリング コーポレイション Aspartyl protease inhibitor
BRPI0909564B8 (en) * 2008-05-28 2021-05-25 Reveragen Biopharma Inc use of a compound
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc Non-hormonal steroid modulators of nf- kappa b for treatment of disease
CN102225959B (en) * 2011-04-29 2012-11-07 中国科学院上海有机化学研究所 16beta-methyl-17alpha-hydroxypreg-3, 20- diketone compound and synthesis thereof
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
CN107840865A (en) * 2016-09-20 2018-03-27 天津金耀集团有限公司 A kind of preparation method of methylprednisolone
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US10953257B2 (en) 2019-04-19 2021-03-23 Kidde Technologies, Inc. Fire suppression composition
US11326998B2 (en) 2019-04-19 2022-05-10 Kidde Technologies, Inc. System and method for monitoring a fire suppression blend
EP4134373A1 (en) 2021-08-12 2023-02-15 Santhera Pharmaceuticals (Schweiz) AG Synthesis of delta 9,11 steroids

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28369E (en) * 1957-02-27 1975-03-18 Atcc-zxs
US3947409A (en) * 1958-06-19 1976-03-30 Merck & Co., Inc. 16-Alkyl-1,4,9(11)-pregnatrienes and 9,11-epoxides thereof
DE1127895B (en) * 1958-12-24 1962-04-19 Ciba Geigy Process for the preparation of pure 9 (11) -unsaturated steroids
US3284477A (en) * 1963-07-10 1966-11-08 Schering Corp Diuretic 1, 4, 9(11)-pregnatrienes
US3639434A (en) * 1967-02-02 1972-02-01 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
US3933799A (en) * 1969-01-29 1976-01-20 Glaxo Laboratories Limited 11β-Halo-9,12-unsubstituted-C19 -steroids
GB1504133A (en) * 1975-02-24 1978-03-15 Palladino G 2-bromo-6beta-fluoro-pregnane compounds
GB1504134A (en) * 1975-02-25 1978-03-15 Palladino G 2-bromo-6beta-fluoro-pregnane compounds
BG33736A3 (en) * 1978-01-25 1983-04-15 Schering Ag,De Method for obtaining of substituated in 17- th position steroids from pregnan row
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
DE3227312A1 (en) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen NEW 6.16 DIMETHYL CORTICOIDS, THEIR PRODUCTION AND USE
DE3640709A1 (en) * 1986-11-28 1988-06-09 Schering Ag METHOD FOR PRODUCING 6 (ALPHA), 9 (ALPHA) -DIFLUOR-11SS, 17 (ALPHA) -DIHYDROXY-16 (ALPHA) -METHYL-4-PREGNEN-3,20-DION AND THEIR DERIVATIVES
US4920216A (en) * 1987-05-28 1990-04-24 The Trustees Of Columbia In The City Of New York Selective chlorination of steroids and other substrates directed by covalently linked pyridine derivatives acting as templates
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids

Also Published As

Publication number Publication date
ATE395353T1 (en) 2008-05-15
EP0969012B1 (en) 2008-05-14
HU227380B1 (en) 2011-05-30
CA2191324A1 (en) 1995-12-07
KR100290226B1 (en) 2001-05-15
FI117599B (en) 2006-12-15
DK0063054T3 (en) 2000-06-19
ES2140678T3 (en) 2000-03-01
EP0969012A2 (en) 2000-01-05
ATE188481T1 (en) 2000-01-15
US5616742A (en) 1997-04-01
HUT75518A (en) 1997-05-28
MX9605893A (en) 1997-12-31
DE69535756D1 (en) 2008-06-26
FI964739A0 (en) 1996-11-28
DE69535765D1 (en) 2008-07-10
IL126597A0 (en) 1999-08-17
EP0969011A2 (en) 2000-01-05
EP0969011B1 (en) 2008-05-28
EP0763054A1 (en) 1997-03-19
IL126598A0 (en) 1999-08-17
DE69514352T2 (en) 2000-08-24
JPH09506113A (en) 1997-06-17
NZ287348A (en) 1998-12-23
EP0763054B1 (en) 2000-01-05
CA2191324C (en) 2001-08-28
US5502222A (en) 1996-03-26
KR100290225B1 (en) 2001-05-15
HU1000527D0 (en) 2010-11-29
ES2306487T3 (en) 2008-11-01
IL113918A0 (en) 1995-08-31
FI20050181A (en) 2005-02-16
GR3032714T3 (en) 2000-06-30
KR100290227B1 (en) 2001-05-15
FI964739A (en) 1996-11-28
EP0969011A3 (en) 2004-10-06
HU227379B1 (en) 2011-05-30
FI118801B (en) 2008-03-31
KR100226568B1 (en) 1999-10-15
ATE397008T1 (en) 2008-06-15
HU227378B1 (en) 2011-05-30
IL126598A (en) 2003-07-31
AU696425B2 (en) 1998-09-10
IL113918A (en) 1999-12-31
WO1995032989A1 (en) 1995-12-07
HU9603299D0 (en) 1997-01-28
JP2831472B2 (en) 1998-12-02
PT763054E (en) 2000-06-30
AU2603595A (en) 1995-12-21
DE69514352D1 (en) 2000-02-10
IL126597A (en) 2003-09-17
FI117600B (en) 2006-12-15
HU0302654D0 (en) 2003-10-28
EP0969012A3 (en) 2004-10-06
ES2306488T3 (en) 2008-11-01
US5750745A (en) 1998-05-12

Similar Documents

Publication Publication Date Title
FI20050180A (en) Process for Preparing Delta 9,11-Chloro-Corticosteroids
NO174621C (en) Process for converting a C4-C6 n-olefin to an iso-olefin
EP0231950A3 (en) Method of nonlinear a/d conversion
JPS55146505A (en) Load current control system
IE821109L (en) Fermentation
GR3004059T3 (en)
EP0246605A3 (en) Conversion of aristeromycin into cyclaradine
JPS57193498A (en) Preparation of 2-bromo-6beta,9alpha-difluoro-11beta,17alpha,21-trihydroxy- 1,4-pregnadiene-3,20-dione-17,21-diesters
FZ Software of power series solution for non-linear free oscillations
EP0302577A3 (en) System for predicting ventricular tachycardia
KR790000589B1 (en) Method for producing 6l-fluoro-17,21-dehydroxy-16b-methylpregna-4,9(11)diene-3,20-dione17,21-diacetate
JPS5344848A (en) Operation controlling method for ac-dc associated system
PFUFF Representation of cracks by dislocations and its application to the fracture toughness of metals
ES478942A1 (en) A process for the selective conversion of 20-methylpregna-3,5,20(21)-triene-3,21-diol-diacetate to 3-oxo-20-methyl-pregna-4,20(21)-diene-21-yl-acetate.
Danilenko et al. Reconstruction of a 250(10 in.) Rod Mill to Produce High Duty Rod
JPS5529272A (en) Cyclo converter
JPS5422852A (en) Dislocation converter
JPS55135441A (en) Optical signal transmission system
ATE48837T1 (en) PROCESS FOR THE PREPARATION OF 2-TERT-BUTYL-4,5DICHLORO-3(2H)-PYRIDAZINONE.
PL263783A1 (en) Method of obtaining 6-alpha-fluoro-16-alpha,17-alpha-isopropylidenedioxy-11-betha,21-dihydroxy-4-pregnene-3,20-dione
FR2598431B1 (en) SACCHAROMYCES STRAINS PRODUCING ALPHA-AMYLASE

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117599

Country of ref document: FI

MM Patent lapsed